Acadia Healthcare Company, Inc. $ACHC Shares Sold by State of Wyoming

State of Wyoming lowered its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 35.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 29,982 shares of the company’s stock after selling 16,188 shares during the quarter. State of Wyoming’s holdings in Acadia Healthcare were worth $701,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of ACHC. EverSource Wealth Advisors LLC grew its stake in Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares in the last quarter. Wells Fargo & Company MN increased its holdings in Acadia Healthcare by 208.9% during the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after purchasing an additional 1,510 shares during the period. Bayforest Capital Ltd acquired a new stake in Acadia Healthcare in the 4th quarter valued at about $52,000. GAMMA Investing LLC boosted its stake in shares of Acadia Healthcare by 124.7% in the 4th quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock valued at $69,000 after buying an additional 2,698 shares during the period. Finally, Caitong International Asset Management Co. Ltd boosted its stake in shares of Acadia Healthcare by 4,264.8% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock valued at $76,000 after buying an additional 5,203 shares during the period.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC opened at $34.01 on Friday. The stock’s 50-day simple moving average is $27.46 and its 200-day simple moving average is $23.10. The firm has a market capitalization of $3.13 billion, a PE ratio of -2.78, a price-to-earnings-growth ratio of 11.60 and a beta of 0.64. Acadia Healthcare Company, Inc. has a fifty-two week low of $11.43 and a fifty-two week high of $35.83. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.71 and a current ratio of 1.71.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The firm had revenue of $828.80 million during the quarter, compared to the consensus estimate of $823.51 million. During the same period in the prior year, the company posted $0.40 earnings per share. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, equities research analysts forecast that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current fiscal year.

Analyst Ratings Changes

ACHC has been the topic of a number of recent research reports. KeyCorp upped their target price on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 14th. Barclays lifted their price target on shares of Acadia Healthcare from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Thursday, April 30th. Raymond James Financial upgraded shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price target for the company in a report on Monday, May 4th. Royal Bank Of Canada increased their price objective on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research report on Monday, May 4th. Finally, Guggenheim lifted their price objective on shares of Acadia Healthcare from $26.00 to $31.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $28.69.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.